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doi:10.1016/j.ejvs.2008.10.005Abstract Introduction: AAA screening programmes have proven to be beneficial and cost
effective worldwide for males greater than 65 years of age, with 4.9% males of 65e75 years
of age having an un-diagnosed AAA at screening, resulting in a 42% reduction in the risk of
rupture in an English population. This study assessed the incidence of AAA and risk factors
for atherosclerosis in Irish males of 55e75 years.
Methods: From April 2006 to December 2007, males between the ages of 55 and 75 years, living
within the catchment area of Blanchardstown Hospital were invited for AAA screening using
duplex ultrasound and cardiovascular risk factor screening.
Results: 1.9% (17/904) of the study population had previously un-diagnosed aneurysms de-
tected, with sizes ranging from 3.0 cm to 5.8 cm (0.6% in 55e65 years old (yo) and 4.2% in
65e75 yo, p< 0.01). 33% (302/904) of patients had hyperlipidaemia, while 16% of those with
a previous diagnosis of hyperlipidaemia, were inadequately controlled on the test date. 31%
of patients had a single elevated blood pressure reading, meriting further investigation for
possible hypertension. 3% (28/904) of all patients had a raised glucose levels which had not
previously been identified and of those who had a previous history of DM, 46% had abnormal
glucose levels. 16% of patients (93/573) were morbidly obese (BMI> 30) and 64% (292/573)
were overweight.
Conclusion: The incidence of AAAs in 65e75-year-old men is similar to international figures.
This study confirms that screening for hyperlipidaemia, hypercholesterolaemia, obesity andeahy, Department of Surgery, Royal College of Surgeons in Ireland and Beaumont Hospital, Dublin 9,
353 1 8093755.
L. Leahy).
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Making the Case for Cardiovascular Screening in Irish Males 301hypertension may be worthwhile in all males over 55 years, while AAA screening should be
reserved for 65e75-year-old Irish males.
ª 2008 Published by Elsevier Ltd on behalf of European Society for Vascular Surgery.Introduction
Cardiovascular disease accounted for 43% of all deaths in
Ireland in 1997.1 The incidence of abdominal aortic
aneurysms (AAAs) has increased in the last two decades,
due in part to an ageing population, with increasing number
of smokers and also improved detection.2 Ruptured AAAs
cause 1.3% of all deaths among males between the ages of
65e85 years.2 One third of untreated AAAs will rupture,
with an associated mortality rate of 65e85%, (half of these
deaths occurring prior to arriving to surgery)3e5. However,
elective repair of these aneurysms has a reported mean
30-day mortality of 2e6%.6,7
AAA screening by ultrasound fulfils all WHO criteria for
screening and is non-invasive using duplex ultrasound, with
a sensitivity of 98.9% and a specificity of 99.9%.8e12 AAA
screening programmes have proven to be beneficial and
cost-effective worldwide for males greater than 65 years of
age,13with 4.9% males of 65 years of age and over having an
un-diagnosed AAA at screening, resulting in a 42% reduction
in the risk of rupture14 in an English population. In Glou-
cestershire a population screening programme performed
ultrasound scanning for all men at age 65. If the aorta was
less than 26 mm in diameter they were reassured and
discharged, as aneurysm disease can be ruled out for 95% of
these patients.15e20
Risk factors for AAA formation include male sex,
smoking, atherosclerosis as well as age21 therefore AAA
screening provides an opportunity to identify patients with
atherosclerotic risk factors. This would allow intervention
to reduce both AAA expansion rates, and also to reduce
other cardiovascular risk factors to improve future
outcome.
This study assessed the incidence of screening detected
AAAs in a population of Irish males from 55 to 75 years of
age, with a view to identifying the ideal age group for
screening. Furthermore patients were stratified for
cardiovascular risk factors, to see if they might potentially
benefit from medical/behavioural management.
Materials and Methods
A cardiovascular risk factor study was initiated by the
vascular department in Connolly Hospital, Blanchardstown
in Dublin from April 2006 to December 2008. Males between
the ages of 55e75 years, living within the catchment area
of the hospital, who were identified from the registers of
General Practitioners, were studied. Exclusion criteria
included patients with terminal medical conditions or
a previous history of AAA.
These patients were invited to attend the vascular unit
for AAA and cardiovascular risk factor screening. Patients
fasted for a minimum of eight hours to enable a fasting lipid
and triglyceride profile to be obtained and also to reduce
bowel gas thereby improving ultrasound imaging of theaorta. Ethical approval was granted by the hospital’s
ethical committee and informed consent was obtained from
every patient in the study.
The screening programme consisted of three parts:
 Duplex ultrasound of aorta
 Clinical risk factor assessment
 Fasting lipid profile
Duplex ultrasound of the aorta was performed in
a standard way by a team of accredited vascular technol-
ogists with the patients in a supine position using a curvi-
linear 3.5 MHz transducer ultrasound probe (General
Electric Logic 9). The protocol was taken from the Society
for Vascular Technology of Great Britain and Ireland.22 If
the aortic diameter was less then 26 mm, the patients were
discharged, as aneurysm disease can be ruled out in 95% of
these patients.23 Follow-up was defined as per interna-
tional guidelines.
A clinical nurse specialist met with each patient.
Their blood pressure, height, weight and body mass
index (BMI) were recorded. Normal blood pressure
values were defined as less than 140 mmHg systolic and
90 mmHg diastolic. Finger prick tests were performed
for total cholesterol, triglyceride and glucose estima-
tion using the Cholestech LDX System (Cholestech,
California). Normal BMI was defined as between 18 and
25.24 Normal cholesterol values, including high density
lipoprotein (HDL) and low density lipoprotein (LDL), as
well as triglyceride values were defined per standard
guidelines.
A fasting serum total cholesterol of 5.0 mm/mol or
greater was classed as hypercholesterolaemia. An
abnormal glucose was defined as a fasting serum glucose of
7.0 mm/mol or greater.25 All abnormal finger prick tests
were confirmed using standard blood samples. The nurse
specialist discussed the patient’s lifestyle and advised
them on changes which would help them prevent or control
their risk factors.
The results of the risk profile and the recommendations
for treatment were referred back to the family practitioner
for follow-up. Patients with AAAs were followed up in the
Vascular Diagnostic Unit of Connolly Hospital.
Statistical comparison between the two groups was by
Chi-squared test with p< 0.05 considered significant.
Results
Using the general practitioners’ register, 1414 patients
were invited to attend and a total of 904 patients accepted
the invitation (64%). Of these, 568 (63%) were aged
between 55 and 64 years (Group A) and 336 (37%) were aged
between 65 and 75 years (Group B). The two groups were
analysed together and then compared to assess their
relative risks.
Table 2 Cholesterol and lipoprotein levels in Group A
(55e64 yo) and Group B (65e75 yo)
55e64 65e75 Total P
Elevated cholesterol 234 105 339 p< 0.01
Hx hypercholesterolaemia
poorly controlled
19 18 37
Un-diagnosed
hypercholesterolaemia
215 87 302
HDL< 1 221 82 303
LDL> 3 279 95 374
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All patients underwent ultrasound of the aorta with 17
(1.9%) having previously un-diagnosed aneurysms with
sizes ranging from 3.0 cm to 5.8 cm. The incidence of AAA
was found to be 0.6% in group A and 4.2% in group B
(p< 0.01).
Two aortas were not successfully imaged due to morbid
obesity and these patients declined further attempts at
imaging.
Risk factors
Smoking
A total of 11% (104/904) of patients were smokers. There
were 6% (58/904) ex-smokers and 82% had never smoked.
Smoking cessation advice was offered to all smokers.
Hypertension (Table 1)
Six patients did not have their blood pressures (BP) recor-
ded as the cuff diameter available was too small to
measure the level accurately. 33% (294/904) of patients
who had a previous history of hypertension and 68% of these
had an isolated elevated blood pressure, despite having
previously been prescribed an anti-hypertensive. 31%
(278/898) of patients with no previous history had a single
elevated blood pressure measurement, suggestive of
hypertension.
Hypercholesterolaemia (Table 2)
26% (234/904) of patients had a previous history of hyper-
cholesterolaemia, with 16% of these being inadequately
controlled. 33% (302/904) of patients were newly diagnosed
with hypercholesterolaemia.
As high density lipoprotein (HDL) and low density
lipoprotein (LDL) values are independent risk factors for
AAA and atherosclerosis development for these values were
also analysed.6,13,26e28
From our results 33% (303/904) of the screened
population had HDL level of less than 1 mmol/l and 41%
(374/904) had LDL level of greater than 3 mmol/l.
Diabetes mellitus (DM) (Table 3)
6% (55/904) of patients had an elevated fasting blood
glucose level; 49% (27/55) of these had a previous history of
diabetes mellitus and had poor blood sugar control. 3%
(28/904) of patients had previously undetected elevated
glucose levels in excess of 7 mmol/l and were referred to
their GP for further investigation and follow-up (Table 3).Table 1 Single raised blood pressure reading in Group A
(55e64 yo) and Group B (65e75 yo)
55e64 65e75 Total P
Single elevated blood
pressure
269 217 486 p< 0.00001
Known hypertension
poorly controlled
105 98 200
No previous history 164 119 278Body mass index (Table 4)
Of the patients who agreed to have their body mass index
measured, 16% (93/573) were morbidly obese (BMI> 30)
and 64% (367/573) were overweight. Overweight patients
received lifestyle advice from the nurse specialist and a risk
profile was sent to their GP.
Discussion
Abdominal aortic aneurysm screening has been shown to be
cost effective in England in men greater than 65 years of
age, significantly reducing the risk of rupture.29 However in
the population of 75 years and older an invitation to
screening has not been shown to reduce all-cause
mortality, since AAA-related mortality accounts for a small
number of deaths in older men.30e32 What is less clear,
however is the cost-effectiveness of screening for AAA in
men between 55 and 65 years of age.6,13,33
This study assessed the effectiveness of studying a pop-
ulation of Irish males for AAA. This study had an attendance
rate of 64% comparable to other Irish studies,1 and slightly
less than other published screening studies.34e36 In men
between 65 and 75 years, 4.2% had AAAs detected, which is
comparable to incidences found in this age group in England
and the United States.10,11,27,28 This would suggest that AAA
screening in this age group in Ireland is justified. The inci-
dence of screening detected AAAs in 55e64-year-old men in
Ireland was 0.6%, which suggests that duplex screening is
not justified or cost-effective in this group (p< 0.01).
Ireland has a high incidence of cardiovascular disease as
previously reported and supported by these results. The
results of this study suggest that screening for cardiovas-
cular risk factors is justified in Irish males over 55 years.
The number of people that never smoked at 82% was quite
surprising and suggests significant under reporting by theTable 3 Diabetes mellitus e poorly controlled and single
elevated fasting blood glucose in Group A (55e64 yo) and
Group B (65e75 yo)
55e64 65e75 Total P
Elevated blood glucose 26 29 55 p< 0.02
Hx diabetes mellitus
poorly controlled
8 19 27
No history 18 10 28
Table 4 Body mass index in Group A (55e64 yo) and Group
B (65e75 yo) including those who declined measurement
BMI 55e64 65e75 Total
BMI> 30 70 23 93
30<Z BMI>Z 25 270 97 367
<25 BMI 76 37 113
Declined 152 179 331
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currently in Ireland in the aftermath of the smoking ban.
The incidence of hyperlipidaemia was notable in this
study population. In patients between 55 and 65 years old,
49% had an abnormally elevated lipid profile. These
patients were educated with dietary advice, recommen-
dations for possible statin therapy if indicated, and urgent
referral back to their family doctor for further investigation
and management. In patients aged 55e64 years old, 41%
had a raised cholesterol level, compared with 31% of 65e74
years old (p< 0.01). As this is a significant difference, it is
suggested that cholesterol and triglyceride screening is
worthwhile in all males between 55 and 75 years of age.
Blood sugar levels were elevated in 6% (55/904) of
patients 46% of them with known DM suggesting poor
control and 3% of patients with no history of DM. All
patients were referred for further investigation and
management to their family practitioners.
80% of the study population was found to be overweight
with 16% morbidly obese. These results are higher than
those previously published in this country and indicate that
obesity is becoming a significant health problem.1
54% of all males had a single elevated blood pressure,
which is suggestive of hypertension. 68% of those with
previously documented hypertension had a raised blood
pressure measurement, which could indicate poor control.
Those with elevated blood pressure readings were referred
to their family practitioner for further blood pressure
measurements in order to determine the presence of
hypertension.
The results of this study would indicate that undiagnosed
and under-treated hypertension, diabetes mellitus and
hypercholesterolaemia are common in Irish males over 50
years of age. Control of hypercholesterolaemia has been
shown to have a 24e35% reduction in coronary events as
well as 30% reduction in cerebrovascular events.37,38 Life-
style modifications would have a significant impact on
reducing these patients’ risk of a cardiovascular event.39,40
This study shows the benefits of AAA screening in Irish males
of 65e75 years; however, screening in males less than 65
years cannot be justified. In the younger group, screening
for cardiovascular risk factors is beneficial both to deter-
mine the rate of un-diagnosed cardiovascular disease and
to monitor and control these risk factors.
A number of conclusions can be drawn from this study,
which is the first report of AAA screening in Irish males. The
incidence of AAAs in 65e75-year-old men is similar to that
in Britain and USA. This suggests that the recent recom-
mendation of the introduction of a national screening
programme in Britain should be imitated in Ireland.41 The
lower incidence of AAAs in Irish males under 65 does not
justify screening in this age group.The high incidence of cardiovascular risk factors in all
males over 55 years is hardly surprising given the recognised
prevalence of atherosclerotic disease in Ireland. This study
confirms that screening for hyperlipidaemia, hyper-
cholesterolaemia, obesity and hypertension in this age
group may be worthwhile.References
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